Correlation between Load of HPV 16 DNA in Cervical Cancer and HPV 16 DNA in Lymph Nodes

References

1. ↵
   1. Moberg M,
   2. Gustavsson I,
   3. Wilander E, et al.

   High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer 2005; 92: 891-894.

   OpenUrlCrossRefPubMedWeb of Science
2. ↵
   1. Sun Y,
   2. Liu GB,
   3. Yu YH, et al.

   Correlation between human papillomavirus DNA in the lymph nodes and metastasis of early-stage cervical carcinoma. Nanfang Yike Daxue Xuebao 2008; 28: 796-798 (Chinese).

   OpenUrl
3. ↵
   1. Huang SL,
   2. Chao A,
   3. Hsueh S, et al.

   Comparison between the Hybrid Capture II Test and an SPF1/GP6 PCR-Based Assay for Detection of Human Papillomavirus DNA in Cervical Swab Samples. JCM 2006; 44: 1733-1739.

   OpenUrl
4. ↵
   1. Häfner N,
   2. Gajda M,
   3. Altgassen C, et al.

   HPV16-E6 mRNA is superior to cytokeratin 19 mRNA as a molecular marker for the detection of disseminated tumour cells in sentinel lymph nodes of patients with cervical cancer by quantitative reverse-transcription PCR. Int J Cancer 2007; 120: 1842-1946.

   OpenUrlCrossRefPubMed
5. ↵
   1. Zheng Y,
   2. Peng ZL,
   3. Lou JY, et al.

   Detection of viral in tegration of HPV-16 in the specimens of the cervical carcinoma and it’s precancerosis by multiplex real-time PCR. Xiandai Fuchanke Jinzhan 2006; 15: 573-577 (Chinese).

   OpenUrl
6. ↵
   1. Cen JM,
   2. Qian DY,
   3. Zeng RH, et al.

   The study of correlation between viral load of high risk human papillomavirus and cervical cancer and precancer. Zhongguo Shiyong Fuke Yu Chanke Zazhi 2007; 23: 533-535 (Chinese).

   OpenUrl
7. ↵
   1. You K,
   2. Geng L,
   3. Guo YL, et al.

   High-risk Human Papillomavirus and the Detection of Viral Load in the Diagnosis of CIN II and III or Cervical Cancer. Zhongguo Weichang Waike Zazhi 2007; 7: 1096-1098 (Chinese).

   OpenUrl
8. ↵
   1. do Horto dos Santos Oliveira L,
   2. Rodrigues Ede V,
   3. de Salles Lopes AP, et al.

   HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene. Sao Paulo Med J 2003; 121: 67-71.

   OpenUrlPubMed
9. ↵
   1. Wang-Johanning F,
   2. Lu DW,
   3. Wang Y, et al.

   Quantitantion of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from Thinprep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer Res 2000; 91: 271-279.

   OpenUrl
10. ↵
    1. Gao ZX,
    2. Ling B,
    3. Zhou Y, et al.

    Significance of human papillomavirus dna detection with fluorescence quantitive PCR in adjacent cervical cancer tissue. Shiyong Aizheng Zazhi 2007; 22: 344-347 (Chinese).

    OpenUrl
11. ↵
    1. Chan PK,
    2. Yu MM,
    3. Cheung TH, et al.

    Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma. J Clin Virol 2005; 33: 201-205.

    OpenUrlPubMedWeb of Science
12. ↵
    1. Slama J,
    2. Drazdakova M,
    3. Dundr P, et al.

    High-risk human papillomavirus DNA in the primary tumor, sentinel, and nonsentinel pelvic lymph nodes in patients with early-stage cervical cancer: a correlation with histopathology. Int J Gynecol Cancer 2009; 19: 703-707.

    OpenUrlPubMed
13. ↵
    1. Lukaszuk K,
    2. Liss J,
    3. Gulczynski J, et al.

    Predictive value of HPV DNA in lymph nodes in surgically treated cervical carcinoma patients-A prospective study. Gynecol Oncol 2007; 104: 721-726.

    OpenUrlPubMed
14. ↵
    1. Juretzka MM,
    2. Jensen KC,
    3. Longacre TA, et al.

    Detection of pelvic lymph node micrometastasis in stage IA2– IB2 cervical cancer by immunohistochemical analysis. Gynecol Oncol 2004; 93: 107-111.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    1. Fule T,
    2. Csapo Z,
    3. Mathe M, et al.

    Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes. Gynecol Oncol 2006; 100: 570-578.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Gillison ML,
    2. Chaturvedi AK,
    3. Lowy DR, et al.

    HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer 2008; 113: 3036-3046.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Begum S,
    2. Westra WH.

    Basaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol 2008; 32: 1044-1050.

    OpenUrlCrossRefPubMedWeb of Science